{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:56:50Z","timestamp":1775041010173,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03695-8","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:59:22Z","timestamp":1774263562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal investigation of the T helper (Th)1-Th2 balance and complement system in clinical high risk for psychosis cohort"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-7119","authenticated-orcid":false,"given":"TianHong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JinYang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoChen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YanYan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MingLiang","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YingYing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HuiRu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhengHui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoHua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HaiChun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZiXuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LingYun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5029-069X","authenticated-orcid":false,"given":"ChunBo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiJun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"3695_CR1","volume":"2","author":"T Zhang","year":"2023","unstructured":"Zhang T, Xu L, Tang X, Wei Y, Hu Y, Cui H, et al. Comprehensive review of multidimensional biomarkers in the shanghai at risk for psychosis (SHARP) program for early psychosis identification. Psychiatry Clin Neurosci Rep. 2023;2:e152.","journal-title":"Psychiatry Clin Neurosci Rep."},{"key":"3695_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1017\/S2045796016000184","volume":"26","author":"TH Zhang","year":"2017","unstructured":"Zhang TH, Li HJ, Woodberry KA, Xu LH, Tang YY, Guo Q, et al. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion. Epidemiol Psychiatr Sci. 2017;26:287\u201398.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"3695_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bbi.2023.03.014","volume":"110","author":"V Mondelli","year":"2023","unstructured":"Mondelli V, Blackman G, Kempton MJ, Pollak TA, Iyegbe C, Valmaggia LR, et al. Serum immune markers and transition to psychosis in individuals at clinical high risk. Brain Behav Immun. 2023;110:290\u20136.","journal-title":"Brain Behav Immun"},{"key":"3695_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1072380","volume":"13","author":"L Ouyang","year":"2022","unstructured":"Ouyang L, Li D, Li Z, Ma X, Yuan L, Fan L, et al. IL-17 and TNF-beta: predictive biomarkers for transition to psychosis in ultra-high risk individuals. Front Psychiatry. 2022;13:1072380.","journal-title":"Front Psychiatry"},{"key":"3695_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/schbul\/sbx057","volume":"43","author":"R Radhakrishnan","year":"2017","unstructured":"Radhakrishnan R, Kaser M, Guloksuz S. The link between the immune system, environment, and psychosis. Schizophr Bull. 2017;43:693\u20137.","journal-title":"Schizophr Bull"},{"key":"3695_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000528770","volume":"82","author":"T Zhang","year":"2023","unstructured":"Zhang T, Zeng J, Wei Y, Ye J, Tang X, Xu L, et al. Changes in inflammatory markers in clinical high risk of developing psychosis. Neuropsychobiology. 2023;82:104\u201316.","journal-title":"Neuropsychobiology"},{"key":"3695_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41380-021-01197-9","volume":"27","author":"M Heurich","year":"2022","unstructured":"Heurich M, Focking M, Mongan D, Cagney G, Cotter DR. Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis. Mol Psychiatry. 2022;27:127\u201340.","journal-title":"Mol Psychiatry"},{"key":"3695_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/pcn.13476","volume":"77","author":"T Zhang","year":"2023","unstructured":"Zhang T, Wei Y, Zeng J, Ye J, Tang X, Xu L, et al. Interleukin-2\/interleukin-6 imbalance correlates with conversion to psychosis from a clinical high-risk state. Psychiatry Clin Neurosci. 2023;77:62\u20133.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3695_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114938","volume":"318","author":"T Zhang","year":"2022","unstructured":"Zhang T, Zeng J, Wei Y, Ye J, Tang X, Xu L, et al. Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: a prospective cohort study. Psychiatry Res. 2022;318:114938.","journal-title":"Psychiatry Res"},{"key":"3695_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1054\/mehy.2000.1203","volume":"56","author":"MJ Schwarz","year":"2001","unstructured":"Schwarz MJ, Muller N, Riedel M, Ackenheil M. The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med Hypotheses. 2001;56:483\u20136.","journal-title":"Med Hypotheses"},{"key":"3695_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1006\/brbi.2001.0647","volume":"15","author":"MJ Schwarz","year":"2001","unstructured":"Schwarz MJ, Chiang S, Muller N, Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav Immun. 2001;15:340\u201370.","journal-title":"Brain Behav Immun"},{"key":"3695_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbi.2023.05.001","volume":"111","author":"P Leon-Ortiz","year":"2023","unstructured":"Leon-Ortiz P, Rivera-Chavez LF, Torres-Ruiz J, Reyes-Madrigal F, Carrillo-Vazquez D, Moncada-Habib T, et al. Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals. Brain Behav Immun. 2023;111:270\u20136.","journal-title":"Brain Behav Immun"},{"key":"3695_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.schres.2016.06.031","volume":"176","author":"M Zeni-Graiff","year":"2016","unstructured":"Zeni-Graiff M, Rizzo LB, Mansur RB, Maurya PK, Sethi S, Cunha GR, et al. Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis. Schizophr Res. 2016;176:191\u20135.","journal-title":"Schizophr Res"},{"key":"3695_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.psychres.2008.11.007","volume":"176","author":"O Freudenreich","year":"2010","unstructured":"Freudenreich O, Brockman MA, Henderson DC, Evins AE, Fan X, Walsh JP, et al. Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR). Psychiatry Res. 2010;176:99\u2013102.","journal-title":"Psychiatry Res"},{"key":"3695_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.psychres.2007.11.014","volume":"160","author":"SM O\u2019Brien","year":"2008","unstructured":"O\u2019Brien SM, Scully P, Dinan TG. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res. 2008;160:256\u201362.","journal-title":"Psychiatry Res"},{"key":"3695_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","volume":"29","author":"MN Noto","year":"2019","unstructured":"Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA Jr, et al. Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol. 2019;29:416\u201331.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3695_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02305-1","volume":"13","author":"T Zhang","year":"2023","unstructured":"Zhang T, Zeng J, Ye J, Gao Y, Hu Y, Xu L, et al. Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk. Transl Psychiatry. 2023;13:9.","journal-title":"Transl Psychiatry"},{"key":"3695_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","volume":"29","author":"TJ Miller","year":"2003","unstructured":"Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703\u201315.","journal-title":"Schizophr Bull"},{"key":"3695_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.schres.2013.11.039","volume":"152","author":"T Zhang","year":"2014","unstructured":"Zhang T, Li H, Woodberry KA, Seidman LJ, Zheng L, Li H, et al. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res. 2014;152:391\u20139.","journal-title":"Schizophr Res"},{"key":"3695_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/pcn.13670","volume":"78","author":"T Zhang","year":"2024","unstructured":"Zhang T, Wei Y, Xu L, Tang X, Hu Y, Liu H, et al. Association between serum cytokines and timeframe for conversion from clinical high-risk to psychosis. Psychiatry Clin Neurosci. 2024;78:385\u201392.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3695_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jclinepi.2013.06.001","volume":"66","author":"O Kuss","year":"2013","unstructured":"Kuss O. The z-difference can be used to measure covariate balance in matched propensity score analyses. J Clin Epidemiol. 2013;66:1302\u20137.","journal-title":"J Clin Epidemiol"},{"key":"3695_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","volume":"18","author":"S Romagnani","year":"1997","unstructured":"Romagnani S. The Th1\/Th2 paradigm. Immunol Today. 1997;18:263\u20136.","journal-title":"Immunol Today"},{"key":"3695_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445\u201389.","journal-title":"Annu Rev Immunol"},{"key":"3695_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2:258\u201370.","journal-title":"Lancet Psychiatry"},{"key":"3695_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","volume":"155","author":"R Upthegrove","year":"2014","unstructured":"Upthegrove R, Manzanares-Teson N, Barnes NM. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res. 2014;155:101\u20138.","journal-title":"Schizophr Res"},{"key":"3695_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2014.00630","volume":"5","author":"J Geginat","year":"2014","unstructured":"Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P, et al. Plasticity of human CD4 T cell subsets. Front Immunol. 2014;5:630.","journal-title":"Front Immunol"},{"key":"3695_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1178334","volume":"327","author":"JJ O\u2019Shea","year":"2010","unstructured":"O\u2019Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science. 2010;327:1098\u2013102.","journal-title":"Science"},{"key":"3695_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri2735","volume":"10","author":"WE Paul","year":"2010","unstructured":"Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified?. Nat Rev Immunol. 2010;10:225\u201335.","journal-title":"Nat Rev Immunol"},{"key":"3695_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","volume":"21","author":"SJ Szabo","year":"2003","unstructured":"Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol. 2003;21:713\u201358.","journal-title":"Annu Rev Immunol"},{"key":"3695_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281:8\u201327.","journal-title":"Immunol Rev"},{"key":"3695_CR31","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39:1003\u201318.","journal-title":"Immunity"},{"key":"3695_CR32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50:1007\u201323.","journal-title":"Immunity"},{"key":"3695_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16:448\u201357.","journal-title":"Nat Immunol"},{"key":"3695_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71:1121\u20138.","journal-title":"JAMA Psychiatry"},{"key":"3695_CR35","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","volume":"41","author":"V Mondelli","year":"2015","unstructured":"Mondelli V, Ciufolini S, Belvederi Murri M, Bonaccorso S, Di Forti M, Giordano A, et al. Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophr Bull. 2015;41:1162\u201370.","journal-title":"Schizophr Bull"},{"key":"3695_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1\u201312.","journal-title":"Brain Behav Immun"},{"key":"3695_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/npp.2016.211","volume":"42","author":"BJ Miller","year":"2017","unstructured":"Miller BJ, Goldsmith DR. Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions. Neuropsychopharmacology. 2017;42:299\u2013317.","journal-title":"Neuropsychopharmacology"},{"key":"3695_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnins.2015.00372","volume":"9","author":"N Muller","year":"2015","unstructured":"Muller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015;9:372.","journal-title":"Front Neurosci"},{"key":"3695_CR39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"3695_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01583-5","volume":"11","author":"A Kalinowski","year":"2021","unstructured":"Kalinowski A, Liliental J, Anker LA, Linkovski O, Culbertson C, Hall JN, et al. Increased activation product of complement 4 protein in plasma of individuals with schizophrenia. Transl Psychiatry. 2021;11:486.","journal-title":"Transl Psychiatry"},{"key":"3695_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbi.2021.11.014","volume":"101","author":"E Ji","year":"2022","unstructured":"Ji E, Boerrigter D, Cai HQ, Lloyd D, Bruggemann J, O\u2019Donnell M, et al. Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain Behav Immun. 2022;101:423\u201334.","journal-title":"Brain Behav Immun"},{"key":"3695_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383.","journal-title":"Nature"},{"key":"3695_CR43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","volume":"39","author":"MK Liszewski","year":"2013","unstructured":"Liszewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, Fara AF, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity. 2013;39:1143\u201357.","journal-title":"Immunity"},{"key":"3695_CR44","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jamapsychiatry.2013.1270","volume":"70","author":"B Nelson","year":"2013","unstructured":"Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, et al. Long-term follow-up of a group at ultra high risk (\u201cprodromal\u201d) for psychosis: the PACE 400 study. JAMA Psychiatry. 2013;70:793\u2013802.","journal-title":"JAMA Psychiatry"},{"key":"3695_CR45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663\u201371.","journal-title":"Biol Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03695-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03695-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03695-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:02:16Z","timestamp":1775034136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03695-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3695"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03695-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for the research (including the consent procedure) was granted by the Institutional Review Board of the Shanghai Mental Health Center (IRB2017-36R) and followed the Declaration of Helsinki. All participants provided written consent to be involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"228"}}